TDI01 suspension

TDI01 · Beijing Tide Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TDI01 suspension, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]

See pricing